Angioneurotic edema attributed to the use of losartan

Archives of Internal Medicine

Volumn 158, Issue 18, 1998, Pages 2063-2065

  Van Rijnsoever, Era W ^a   Kwee Zuiderwijk, Wilma J M ^b   Feenstra, Johannes ^c,d  

^a Pharmacy Apotheek Leusden   (Netherlands)

^b Netherlands Pharmacovigilance Found   (Netherlands)

^c Drug Safety U Insp for Hlth Care   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN POTASSIUM;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DOSE RESPONSE; ENZYME ACTIVITY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MALE; NETHERLANDS; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ADULT; AGED; ANGIONEUROTIC EDEMA; ANTI-ARRHYTHMIA AGENTS; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; LOSARTAN; MALE; MIDDLE AGED; RECEPTORS, ANGIOTENSIN;

EID: 0032511740     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.18.2063     Document Type: Article

References (18)

1. Megerian CA, Arnold JE, Berger M. Angioedema: 5 years experience with a review of the disorder's presentation and treatment. Laryngoscope. 1992;102:256-260.
2. Bauwens LJJM, Copper MP, Schmidt JTH. Levensbedreigend angio-oedeem als bijwerking van angiotensine-converting-enzym (ACE)-remmers. Ned Tijdschr Geneeskd. 1995;139:674-677.
3. Lanting PJH, Brouwers TM, van Buuren HR, Stricker BHCh. Angiooedeem ten gevolge van enalapril. Pharm Weekbl. 1991;126:228-231.
4. Orfan N, Patterson R, Dykewicz MS. Severe angioedema related to ACE inhibitors in patients with a history of idiopathic angioedema. JAMA. 1990; 264:1287-1289.
5. Hedner T, Samuelsson O, Lunde H, Lindholm L, Andrén L, Wilholm BE. Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors. BMJ. 1992;304:941-946.
6. Israili ZH, Dallas Hall W. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med. 1992;117:234-242.
7. Burrell LM. A risk benefit assessment of losartan potassium in the treatment of hypertension. Drug Saf. 1997;16:56-65.
8. Brunner HR, Nussberger J, Waeber B. Angiotensin II blockade compared with other pharmacological methods of inhibiting the reninangiotensin system. J Hypertens Suppl. 1993;11: 553-558.
9. Goldberg AI, Dunlay MC, Sweet CS. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. Am J Cardiol. 1995;75:793-795.
10. Boxer M. Accupril- and cozaar-induced angioedema in the same patient. J Allergy Clin Immunol. 1996;98:471.
11. Acker CG, Greenberg A. Angioedema induced by the angiotensin-II-blocker losartan. N Engl J Med. 1995;333:1572.
12. Johnston CI. Angiotensin receptor antagonists: focus on losartan. Lancet. 1995;346:1403-1407.
13. Barrow SE, Dollery CT, Heavey DJ, Hickling NE, Ritter JM, Vial J. Effect of vasoactive peptides on prostacyclin synthesis in man. Br J Pharmacol. 1986;87:243-247.
14. Cockcroft JR, Sciberras DG, Goldberg MR, Ritter JM. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm. J Cardiovasc Pharmacol. 1993;22:579-584.
15. Gabb GM, Ryan P, Wing LMH, Hutchinson KA. Epidemiological study of angioedema and ACE inhibitors. Aust N Z J Med. 1996;26:777-782.
16. Shepherd GM. Possible contraindication of angiotensin-converting enzyme inhibitors in patients with hereditary angioedema. Am J Med. 1990;88:446.
17. Agostini A, Cicardi M. Contraindications to the use of ACE inhibitors in patients with C1 esterase inhibitor deficiency. Am J Med. 1991;90:278.
18. van Zwieten PA, Lie K. Medicamenteuze angiotensine II-receptorblokkade bij hypertensie en hartfalen. Ned Tijdschr Geneeskd. 1995;139:1529-1533.